Left ventricular wall thicknesses are normal.
Overall left ventricular systolic function is normal (LVEF>55%).
The RV systolic function is borderline low normal.
The LV systolic function is borderline normal with no new wall motion abnormalities.
[**2112-1-1**] CXR: FINDINGS: In comparison with the study of [**12-30**], there is partial clearing of the bilateral atelectatic change, though opacification persists in the retrocardiac region at the left base.
[**2111-12-29**] 11:32AM BLOOD WBC-1.6*# RBC-2.80*# Hgb-8.8*# Hct-25.0*# MCV-90 MCH-31.4 MCHC-35.1* RDW-13.5 Plt Ct-95* [**2111-12-29**] 12:10PM BLOOD WBC-4.7# RBC-3.44* Hgb-10.6* Hct-30.6* MCV-89 MCH-30.8 MCHC-34.7 RDW-13.5 Plt Ct-103* [**2111-12-29**] 07:15PM BLOOD Hct-32.3* [**2111-12-30**] 04:16AM BLOOD WBC-6.1 RBC-3.54* Hgb-11.2* Hct-31.6* MCV-89 MCH-31.6 MCHC-35.4* RDW-13.5 Plt Ct-100* [**2111-12-31**] 04:16AM BLOOD WBC-7.6 RBC-3.70* Hgb-11.5* Hct-32.5* MCV-88 MCH-31.0 MCHC-35.3* RDW-13.4 Plt Ct-99* [**2112-1-1**] 05:05AM BLOOD WBC-5.7 RBC-3.46* Hgb-10.7* Hct-31.1* MCV-90 MCH-31.0 MCHC-34.4 RDW-13.4 Plt Ct-102* [**2111-12-29**] 11:32AM BLOOD PT-15.4* PTT-36.1* INR(PT)-1.3* [**2111-12-29**] 11:32AM BLOOD Plt Smr-LOW Plt Ct-95* [**2111-12-29**] 12:10PM BLOOD PT-14.4* PTT-38.4* INR(PT)-1.2* [**2111-12-29**] 12:10PM BLOOD Plt Ct-103* [**2111-12-30**] 04:16AM BLOOD Plt Ct-100* [**2111-12-31**] 04:16AM BLOOD Plt Smr-LOW Plt Ct-99* [**2112-1-1**] 05:05AM BLOOD Plt Ct-102* [**2111-12-29**] 12:10PM BLOOD UreaN-16 Creat-0.9 Na-142 K-4.3 Cl-112* HCO3-25 AnGap-9 [**2111-12-29**] 07:15PM BLOOD Na-142 K-4.2 Cl-112* [**2111-12-30**] 04:16AM BLOOD Glucose-122* UreaN-17 Creat-0.9 Na-140 K-4.5 Cl-109* HCO3-26 AnGap-10 [**2111-12-31**] 04:16AM BLOOD Glucose-128* UreaN-20 Creat-1.0 Na-136 K-3.8 Cl-100 HCO3-31 AnGap-9 [**2112-1-1**] 05:05AM BLOOD UreaN-21* Creat-1.0 Na-138 K-3.9 Cl-100 [**2112-1-1**] 11:12PM BLOOD Glucose-112* UreaN-18 Creat-1.0 Na-137 K-4.2 Cl-99 HCO3-31 AnGap-11  Brief Hospital Course: The patient was brought to the operating room on [**2111-12-29**] where the patient underwent mitral valve repair with 28mm ring.
Medications on Admission: CITALOPRAM - 40 mg Tablet - 1 Tablet(s) by mouth once a day ERGOCALCIFEROL (VITAMIN D2) [VITAMIN D] - 50,000 unit Capsule - one Capsule(s) by mouth qweek FUROSEMIDE - 20 mg Tablet - [**11-22**] tab Tablet(s) by mouth once a day - No Substitution LISINOPRIL - 40 mg Tablet - 1 Tablet(s) by mouth once a day METOPROLOL SUCCINATE - 50 mg Tablet Sustained Release 24 hr - 1 Tablet(s) by mouth once a day - No Substitution SILDENAFIL [VIAGRA] - 100 mg Tablet - 1 Tablet(s) by mouth as directed ASPIRIN -  (OTC) - 81 mg Tablet, Chewable - 1 Tablet(s) by mouth daily CALCIUM CITRATE [CALCITRATE] -  (Prescribed by Other Provider) - 200 mg (950 mg) Tablet - 1 (One) Tablet(s) by mouth twice a week CYANOCOBALAMIN (VITAMIN B-12) -  (Prescribed by Other Provider) - 1,000 mcg Tablet Sustained Release - 1 Tablet(s) by mouth twice a week ERGOCALCIFEROL (VITAMIN D2) [VITAMIN D] -  (OTC) - 1,000 unit Capsule - 1 Capsule(s) by mouth daily RANITIDINE HCL -  (OTC) - 150 mg Tablet - 1 Tablet(s) by mouth prn as needed for GERD   Discharge Medications: 1. aspirin 81 mg Tablet, Delayed Release (E.C.)
